Centrus Energy enters its August 4 earnings date carrying one of the most charged short-side setups in the market — shorts near a monthly high, zero borrow availability, and options traders rotating toward calls even as the stock drifts lower.
The borrow market tells the sharpest story. Availability has been at or near zero for most of July — every share in the lending pool is already out on loan. That follows a period in mid-to-late June when availability briefly ran as high as 10%, but by early July the pool closed off almost entirely. Short interest has climbed alongside, reaching 27.7% of the free float on July 28, up 24% from a month ago. FINRA's fortnightly figure pegs short shares at roughly 5 million with 5.3 days to cover. Cost to borrow, while not extreme at 1.5%, jumped 11.5% over the past week — a sign that the scramble to find lendable shares is nudging up marginal borrow rates. With the borrow exhausted and short interest still building, the setup is technically primed for a squeeze, though the high conviction among shorts suggests they are not easily spooked.
What's notable is that options traders are not adding to that bearish pile. The put/call ratio has slid to 0.65, well below its 20-day average of 0.70 and close to the lowest reading of the past year. That's 1.3 standard deviations below the mean — an unusual skew toward calls in a name that's down nearly 1% on the week and has seen the stock fall 3.6% in a single session on Tuesday. The divergence between a record-tight borrow market and call-heavy options positioning is the central tension heading into the print.
The Street has been consistently trimming targets all year, and that continued this week. JP Morgan's Bill Peterson cut his price target sharply — from $236 to $178 — while maintaining a Neutral rating, the most significant single move in months and one that lands just above the current price of $169.65. The mean analyst target across the coverage universe is $259, implying roughly 53% upside, though that number is pulled higher by the Buy camp. Needham and B. Riley both hold Buy ratings with targets well above $200, while JP Morgan, BofA Securities, Citi, Roth Capital, and UBS all sit at Neutral. Truist initiated with a Buy two weeks ago at $215. The pattern is a Street that still sees long-term value in Centrus's nuclear fuel franchise but is marking down near-term targets to reflect execution uncertainty. The bull case rests on the $900 million DOE award and the prospect of domestic LEU production scaling at Piketon; bears point to ongoing reliance on TENEX for supply and the absence of a firm capital budget for the $5–7 billion expansion. The ORTEX short score at 75.0 sits near a six-month high, while the EV/EBITDA multiple — around 38.8x — has compressed roughly 3.2 points over the past 30 days as the stock has drifted.
Institutional flows add a layer of interest. State Street added 446,000 shares in the quarter to June 30, and Bank of Nova Scotia added 567,000 — both material builds relative to the float. Van Eck added 321,000. BlackRock, the largest declared holder at 7.3% of shares, added a smaller 75,000. The aggregate picture is institutions rebuilding positions even as sell-side targets fall — a split that reinforces the bull-versus-bear standoff.
Earnings reactions for LEU have been erratic: the last four prints produced moves of +7.9%, −10.4%, +0.1%, and +11.8% on the day. With zero borrow availability, any sharp move to the upside would leave short sellers with virtually no ability to increase the hedge without pushing the stock higher themselves; the August 4 print is the next event that could resolve that tension.
See the live data behind this article on ORTEX.
Open LEU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
